His research is interdisciplinary, bridging the disciplines of Senile plaques and Disease. He performs multidisciplinary studies into Internal medicine and Oncology in his work. In his works, Thomas J. Montine conducts interdisciplinary research on Oncology and Internal medicine. He conducted interdisciplinary study in his works that combined Pathology and Neuropathology. His work blends Neuropathology and Alzheimer's disease studies together. While working in this field, Thomas J. Montine studies both Alzheimer's disease and Senile plaques. His research is interdisciplinary, bridging the disciplines of Biomarker and Biochemistry. Biomarker and Biochemistry are commonly linked in his work. Thomas J. Montine undertakes interdisciplinary study in the fields of Dementia and Dementia with Lewy bodies through his research.
Thomas J. Montine combines topics linked to Apolipoprotein E with his work on Disease. Thomas J. Montine incorporates Internal medicine and Endocrinology in his studies. While working on this project, Thomas J. Montine studies both Endocrinology and Internal medicine. His research on Pathology frequently links to adjacent areas such as Dementia. His multidisciplinary approach integrates Dementia and Alzheimer's disease in his work. In most of his Alzheimer's disease studies, his work intersects topics such as Pathology. Biochemistry and Neuroscience are two areas of study in which Thomas J. Montine engages in interdisciplinary work. He undertakes multidisciplinary investigations into Neuroscience and Biochemistry in his work. In his works, Thomas J. Montine conducts interdisciplinary research on Gene and Genetics.
Thomas J. Montine regularly links together related areas like Parkinson's disease in his Disease studies. His research on Parkinson's disease often connects related areas such as Disease. Thomas J. Montine performs integrative Pathology and Psychiatry research in his work. He undertakes interdisciplinary study in the fields of Psychiatry and Pathology through his research. He frequently studies issues relating to Cohort and Internal medicine. His Internal medicine research extends to Cohort, which is thematically connected. By researching both Neuroscience and Cognition, Thomas J. Montine produces research that crosses academic boundaries. He applies his multidisciplinary studies on Cognition and Neuroscience in his research. Thomas J. Montine integrates Gene and Biochemistry in his research.
Thomas J. Montine has begun a study into Alzheimer's disease, looking into Senile plaques and Tau protein. Thomas J. Montine performs integrative Senile plaques and Dementia research in his work. Thomas J. Montine regularly links together related areas like Cognitive decline in his Dementia studies. Thomas J. Montine integrates several fields in his works, including Tau protein and Central nervous system. He performs multidisciplinary studies into Central nervous system and Cerebrospinal fluid in his work. His Cerebrospinal fluid study frequently links to other fields, such as Neuroscience. While working on this project, Thomas J. Montine studies both Neuroscience and Computational biology. While working on this project, Thomas J. Montine studies both Computational biology and Bioinformatics. In his research, he undertakes multidisciplinary study on Bioinformatics and Metabolomics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
Mohsen Naghavi;Haidong Wang;Rafael Lozano;Adrian Davis.
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos;Ryan M. Barber;Brad Bell;Amelia Bertozzi-Villa.
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang;Mohsen Naghavi;Christine Allen;Ryan M Barber.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday.
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman;Creighton H. Phelps;Thomas G. Beach;Eileen H. Bigio.
Alzheimers & Dementia (2012)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
Thomas J. Montine;Creighton H. Phelps;Thomas G. Beach;Eileen H. Bigio.
Acta Neuropathologica (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: